Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,816,586
+$1,285,379 QoQ
Shares Held
3,182
+15.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,929
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. LLY ranks #4 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,816,586 | 3,182 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,531,207 | 2,752 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,845,752 | 2,648 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,829,674 | 2,398 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,810,848 | 2,323 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,871,512 | 2,266 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,743,176 | 2,258 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,954,383 | 2,206 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,171,070 | 6,816 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,261,343 | 6,763 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $3,911,976 | 6,711 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,724,996 | 6,935 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,159,518 | 6,737 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,294,732 | 6,682 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,519,905 | 6,888 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,961,764 | 6,067 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,923,008 | 5,931 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,668,677 | 5,827 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,693,781 | 6,132 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,422,574 | 6,157 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,390,432 | 6,058 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $1,131,755 | 6,058 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $1,019,624 | 6,039 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $898,629 | 6,071 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $961,109 | 5,854 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $812,066 | 5,854 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||